EE92 Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test for HR+/HER2- Early-Stage Breast Cancer in the US
| Autor: | Berdunov, V, Cuyun Carter, G, Laws, E, Luo, R, Russell, C, Campbell, S, Force, J, Abdou, YG |
|---|---|
| Zdroj: | In Value in Health July 2022 25(7) Supplement:S352-S353 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect